ПОИСК ПО САЙТУ 
поиск по ресурсному центру At its September meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended for approval a generic version of Truvada – Emtricitabine/Tenofovir disoproxil Zentiva (emtricitabine/tenofovir disoproxil) for the treatment of HIV infection.
Summary of opinion for Emtricitabine/Tenofovir disoproxil Zentiva is available here.
